about
Truncating and missense mutations in IGHMBP2 cause Charcot-Marie Tooth disease type 2.Treatment outcomes in older patients with advanced gastrointestinal stromal tumor (GIST).IDH1/2 Mutations Predict Shorter Survival in Chondrosarcoma.Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case SeriesImmunotherapy of melanomaBlood neutrophil-to-lymphocyte ratio is associated with prognosis in advanced gastrointestinal stromal tumors treated with imatinibHigh baseline neutrophil-to-lymphocyte ratio predicts worse outcome in patients with metastatic BRAF-positive melanoma treated with BRAF and MEK inhibitorsValue of planar lymphoscintigraphy (PL) versus SPECT/CT in evaluation of sentinel lymph node in trunk melanoma - one center, large series retrospective studyCell-free DNA BRAF V600E measurements during BRAF inhibitor therapy of metastatic melanoma: long-term analysisSystemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma NetworkComparison of seventh and eighth edition of AJCC staging system in melanomas at locoregional stage.Treatment Sequencing and Clinical Outcomes in BRAF-Positive and BRAF-Negative Unresectable and Metastatic Melanoma Patients Treated with New Systemic Therapies in Routine PracticePrognostic value of the pretreatment neutrophil-to-lymphocyte ratio in patients with advanced gastrointestinal stromal tumors treated with sunitinib after imatinib failure
P50
Q34478330-80A6473F-76A9-4E81-874D-117F76FA0CA2Q51731979-32B194AC-C4B3-4B3E-BBC2-852BAAB8D01CQ52629240-2D6650FE-1C68-44DC-9CEE-03CEF2C6D1B3Q56386491-8BAE196F-6417-4284-93C1-5E37E9EAAF47Q56892854-17BABE6C-C90E-4A85-8334-59606ED6CF08Q88530418-8AA19604-49EB-41FF-B7E2-1F5557798ED6Q88755930-DA4C89E9-F001-405B-9AA6-56A835D058D2Q89341743-11ECA32B-54DB-48A2-85DC-196AE30A9F8FQ89569190-E4019CEE-4D46-45CD-AA8A-60A8EB98956EQ90179286-50428016-8153-4FE9-BF15-BA2838AD91F3Q91013721-EAC13366-CF6F-4A35-B6A8-CD2350C547CBQ91389967-1B2C265F-9D4D-4045-80FD-D1A2035053DAQ92890326-FE0C0C84-72FB-4D81-953E-DC68197AF10A
P50
description
researcher
@en
wetenschapper
@nl
name
Pawel Teterycz
@en
Pawel Teterycz
@nl
type
label
Pawel Teterycz
@en
Pawel Teterycz
@nl
prefLabel
Pawel Teterycz
@en
Pawel Teterycz
@nl
P31
P496
0000-0001-7304-714X